Clinical TrialsSearch results
Number of results: 230
Recruiting
- Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects with Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
- Advanced or Metastatic PD L1 High (TPS >=50%) Non-small Cell Lung Cancer
- Inoguchi Akihiro
- 2022-02-05
Other
- Phase 1/2 study of Multiple-Vaccine with CpG-ODN Therapy in Patient with Refractory Colon Cancer to Chemotherapy.
- Colon Cancer
- Institute of Medical Science, The university of Tokyo.
- 2009-08-28
Recruiting
- Phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with polymyalgia rheumatica (PMR)
- Polymyalgia Rheumatica
- Iwasaki Ryohei
- 2023-04-29
Other
- Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy.
- Prostate cancer
- J-CaP study group
- 2006-12-30
Other
- Outcome study of hormonal therapy for prostate cancer in Japan
- Prostate cancer
- J-CaP study group
- 2005-09-29
Other
- Assessment of Beta-Blocker Treatment in Japanese Patients with Chronic Heart Failure
- Chronic heart failure
- J-CHF Study Group
- 2006-12-13
Other
- Japanese Diastolic Heart Failure Study
- Diastolic heart failure
- J-DHF Study group
- 2006-02-01
Completed
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants with Guillain-Barre Syndrome
- Guillain Barre Syndrome
- James Overell
- 2022-10-01
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17